Literature DB >> 17457666

P300 cognitive evoked potentials before and after liver transplantation.

Roy R Reeves1, Frederick A Struve, Carla J Rash, Randy S Burke.   

Abstract

P300 cognitive evoked potentials have been shown to be effective for the assessment of mild hepatic encephalopathy but no investigations of their use with liver transplantation has been conducted. In this pilot study 12 subjects (7 male, 5 female, average age 43.9-years-old) underwent recording of auditory and visual P300 cognitive evoked potentials prior to liver transplantation and again 3-6 months subsequent to transplantation. Significant increases (p < 0.01) in P300 visual amplitude, as well as significant decreases in visual (p < 0.01) and auditory latencies (p < 0.01) were observed following transplantation. Auditory amplitudes increased but not to a statistically significant degree. P300 cognitive evoked potentials may provide a useful tool for monitoring the cerebral status of liver transplantation patients if combined with established methods such as cognitive testing and EEG. Further research of their usage with these patients is warranted.

Entities:  

Mesh:

Year:  2007        PMID: 17457666     DOI: 10.1007/s11011-007-9055-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy.

Authors:  Nandini Saxena; Manvir Bhatia; Yogendra K Joshi; Pramod K Garg; Sada Nand Dwivedi; Rakesh K Tandon
Journal:  Liver       Date:  2002-06

Review 3.  Neurophysiological investigation of hepatic encephalopathy.

Authors:  Piero Amodio; Angelo Gatta
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  EEG and event related potentials in hepatic encephalopathy.

Authors:  M G Davies; M J Rowan; J Feely
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

5.  Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

Authors:  H O Conn
Journal:  Am J Dig Dis       Date:  1977-06

6.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

7.  Cognitive event-related potential in hepatic encephalopathy.

Authors:  V Gallai; A Alberti; S Balò; G Mazzotta; C Clerici; G Gentili; C Firenze; A Morelli
Journal:  Acta Neurol Scand       Date:  1995-05       Impact factor: 3.209

8.  The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease.

Authors:  M G Davies; M J Rowan; P MacMathuna; P W Keeling; D G Weir; J Feely
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

Review 9.  Cerebral changes in hepatic encephalopathy.

Authors:  A Watanabe
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

10.  [Visual P300 in acute hepatic encephalopathy resulting from non-A-non-B fulminant hepatitis: analysis of the course before and after orthotopic liver transplantation].

Authors:  C F Kügler; A Taghavy; W E Fleig; E G Hahn
Journal:  EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb       Date:  1991-12
View more
  2 in total

Review 1.  Neurocognitive-neurological complications of liver transplantation: a review.

Authors:  Francesca Campagna; A Biancardi; U Cillo; A Gatta; P Amodio
Journal:  Metab Brain Dis       Date:  2010-03-05       Impact factor: 3.584

2.  Modulation of neural activation following treatment of hepatic encephalopathy.

Authors:  Mark J W McPhail; Robert Leech; Vijay P B Grover; Julie A Fitzpatrick; Novraj S Dhanjal; Mary M E Crossey; Henning Pflugrad; Brian K Saxby; Keith Wesnes; M Alex Dresner; Adam D Waldman; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.